GL1X · GenesisL1 explorer

MolNFT v2 · #125777 · protein

Targeting the PEX14-PEX5 interaction by small molecules provides novel therapeutic routes to treat trypanosomiases.

5L87: “Targeting the PEX14-PEX5 interaction by small molecules provides novel therapeutic routes to treat…”. X-ray diffraction at 0.87, 1 ligand (6RD). MolNFT v2 #125777 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5L87
Type
protein
Length
62 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
0.87
Source
Trypanosoma brucei brucei
UniProt
Q8IEW2
Ligands
6RD

Structure

x-ray diffraction · resolution 0.87 · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein62—Q8IEW2

Ligands and binding sites

  • 6RD · 5-(1~{H}-indol-3-ylmethyl)-1-methyl-~{N}-(naphthalen-1-ylmethyl)-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridine-3-carboxamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5L87 · Targeting the PEX14-PEX5 interaction by small molecules provides novel therapeutic routes… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.